NCT01795950 Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE1
NCT01781052 Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients Status COMPLETED Phase N/A
NCT01757808 A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE1
NCT01743001 Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome Status COMPLETED Phase PHASE3
NCT01739400 Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome Status TERMINATED Phase PHASE3
NCT01725269 Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05 Status TERMINATED Phase PHASE2
NCT01725256 A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE2
NCT01723371 Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children Status WITHDRAWN Phase PHASE1/PHASE2
NCT01712997 Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients Status UNKNOWN Phase PHASE3
NCT01649739 Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost Status UNKNOWN Phase PHASE4
NCT01642407 Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE4
NCT01637675 Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension Status UNKNOWN Phase PHASE2/PHASE3
NCT01615627 Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain Status WITHDRAWN Phase PHASE4